Clinical Trials
Study Title:
Melanoma Margins Trial (MelMarT II): A Phase III, Multi Centre, Multi National Randomized Control Trial investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Andrea Abbott, at abbottan@musc.edu. Study Coordinator, Eva Newman, at newmanev@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |